Michael E Sughrue

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi Pre-operative dopamine agonist therapy improves post-operative tumor control following prolactinoma resection
    Michael E Sughrue
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA, USA
    Pituitary 12:158-64. 2009
  2. doi Reconstruction of dural defects of the endonasal skull base
    Michael E Sughrue
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA 94117, USA
    Neurosurg Clin N Am 21:637-41, vi. 2010
  3. doi Complication avoidance in minimally invasive neurosurgery
    Michael E Sughrue
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA 94117, USA
    Neurosurg Clin N Am 21:699-702, vii-viii. 2010
  4. doi Excess mortality for patients with residual disease following resection of pituitary adenomas
    Michael E Sughrue
    California Center for Pituitary Disorders, University of California, 400 Parnassus Avenue, Room A 808, San Francisco, CA 94143 0350, USA
    Pituitary 14:276-83. 2011
  5. doi Results with judicious modern neurosurgical management of parasagittal and falcine meningiomas. Clinical article
    Michael E Sughrue
    Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California, USA
    J Neurosurg 114:731-7. 2011
  6. doi Management of recurrent intracranial hemangiopericytoma
    Martin J Rutkowski
    Brain Tumor Research Center, Department of Neurological Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    J Clin Neurosci 18:1500-4. 2011
  7. doi Modern surgical outcomes following surgery for sphenoid wing meningiomas
    Michael E Sughrue
    Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California 94143, USA
    J Neurosurg 119:86-93. 2013
  8. doi Intracranial hemangiopericytoma: clinical experience and treatment considerations in a modern series of 40 adult patients
    Martin J Rutkowski
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, California, USA
    Cancer 118:1628-36. 2012
  9. doi Extent of resection and the long-term durability of vestibular schwannoma surgery
    Michael E Sughrue
    Department of Neurological Surgery, University of California, San Francisco, California 94143, USA
    J Neurosurg 114:1218-23. 2011
  10. doi Risk factors for the development of serious medical complications after resection of meningiomas. Clinical article
    Michael E Sughrue
    Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California, USA
    J Neurosurg 114:697-704. 2011

Collaborators

Detail Information

Publications75

  1. doi Pre-operative dopamine agonist therapy improves post-operative tumor control following prolactinoma resection
    Michael E Sughrue
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA, USA
    Pituitary 12:158-64. 2009
    ..We sought to determine whether preoperative treatment with dopamine agonists alters the outcome of surgical intervention...
  2. doi Reconstruction of dural defects of the endonasal skull base
    Michael E Sughrue
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA 94117, USA
    Neurosurg Clin N Am 21:637-41, vi. 2010
    ..In this review, the authors discuss known techniques for the repair of endonasal defects, and provide some insight based on their experience...
  3. doi Complication avoidance in minimally invasive neurosurgery
    Michael E Sughrue
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA 94117, USA
    Neurosurg Clin N Am 21:699-702, vii-viii. 2010
    ..This article provides practical information regarding known pitfalls in intraventricular and transcranial neuroendoscopic surgeries and practical methods to reduce the incidence of these complications to the lowest rate possible...
  4. doi Excess mortality for patients with residual disease following resection of pituitary adenomas
    Michael E Sughrue
    California Center for Pituitary Disorders, University of California, 400 Parnassus Avenue, Room A 808, San Francisco, CA 94143 0350, USA
    Pituitary 14:276-83. 2011
    ....
  5. doi Results with judicious modern neurosurgical management of parasagittal and falcine meningiomas. Clinical article
    Michael E Sughrue
    Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California, USA
    J Neurosurg 114:731-7. 2011
    ..The present study aims to address surgical outcomes in a focused cohort of these patients for which there is not clinical equipoise between radiosurgery and transcranial resection...
  6. doi Management of recurrent intracranial hemangiopericytoma
    Martin J Rutkowski
    Brain Tumor Research Center, Department of Neurological Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    J Clin Neurosci 18:1500-4. 2011
    ..This multimodality approach also appears to outperform GKS in extending time to second recurrence. Accordingly, when safe and feasible, surgical resection of recurrent HPC with adjuvant EBRT should be the first steps in management...
  7. doi Modern surgical outcomes following surgery for sphenoid wing meningiomas
    Michael E Sughrue
    Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California 94143, USA
    J Neurosurg 119:86-93. 2013
    ..The authors review their experience with resection of sphenoid wing meningiomas at a single center, to examine whether this classification predicts clinical presentation and postsurgical outcome...
  8. doi Intracranial hemangiopericytoma: clinical experience and treatment considerations in a modern series of 40 adult patients
    Martin J Rutkowski
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, California, USA
    Cancer 118:1628-36. 2012
    ..Intracranial hemangiopericytoma (HPC) is a malignant meningothelial tumor. Because of its rarity, few guidelines exist for optimal management...
  9. doi Extent of resection and the long-term durability of vestibular schwannoma surgery
    Michael E Sughrue
    Department of Neurological Surgery, University of California, San Francisco, California 94143, USA
    J Neurosurg 114:1218-23. 2011
    ..In this prospective study, the authors evaluated 772 patients who underwent microsurgical resection of VSs to analyze the association between total tumor resection and the tumor recurrence rate...
  10. doi Risk factors for the development of serious medical complications after resection of meningiomas. Clinical article
    Michael E Sughrue
    Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California, USA
    J Neurosurg 114:697-704. 2011
    ..The authors performed a review of 834 patients who underwent craniotomy for meningioma at their institution and analyzed the rate of major cardiac, pulmonary, renal, and hepatic complications...
  11. doi A critical evaluation of cystic features in primary glioblastoma as a prognostic factor for survival
    Gurvinder Kaur
    Department of Neurological Surgery, University of California, San Francisco, California, USA
    J Neurosurg 115:754-9. 2011
    ....
  12. doi Tumor control after surgery and radiotherapy for pineocytoma
    Aaron J Clark
    Department of Neurological Surgery, University of California, San Francisco, California 94117, USA
    J Neurosurg 113:319-24. 2010
    ..Therefore, the authors performed a systematic review of the literature on tumor control after surgery for pineocytoma to determine the relative benefits of aggressive resection and postoperative adjuvant radiotherapy...
  13. doi A meta-analysis of tumor control rates and treatment-related morbidity for patients with glomus jugulare tumors
    Michael E Ivan
    Department of Neurological Surgery, University of California, San Francisco, California, USA
    J Neurosurg 114:1299-305. 2011
    ..In this study, the authors assessed data collected from 869 patients with glomus jugulare tumors from the published literature to identify treatment variables that impacted clinical outcomes and tumor control rates...
  14. pmc Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma
    Michael E Sughrue
    Department of Neurological Surgery, University of California at San Francisco, 505 Parnassus Ave, San Francisco, CA 94117, USA
    J Neurooncol 101:463-76. 2011
    ..4%, P = 0.11). Given the difficulty in obtaining class 1 data regarding the treatment of this tumor, this study can serve as an estimate of expected outcomes for these patients, and guide decision making until these data are available...
  15. doi Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas
    Michael E Sughrue
    Brain Tumor Research Center, Department of Neurological Surgery, University of California at San Francisco, California 94143, USA
    J Neurosurg 113:202-9. 2010
    ..The authors present the largest case series to date dealing with these tumors, providing analysis of 63 patients...
  16. doi Clinical and surgical considerations for cerebellopontine angle meningiomas
    Ari J Kane
    Department of Neurological Surgery, Brain Tumor Research Center, University of California at San Francisco, San Francisco, CA 94143, USA
    J Clin Neurosci 18:755-9. 2011
    ..Caution must be used when attempting to resect tumor extensions into the jugular foramen given the high rates of lower CN complications...
  17. pmc Factors associated with preservation of facial nerve function after surgical resection of vestibular schwannoma
    Orin Bloch
    Department of Neurological Surgery, University of California at San Francisco, 505 Parnassus Ave, San Francisco, CA 94143, USA
    J Neurooncol 102:281-6. 2011
    ..Residual disease can be followed and controlled with radiosurgery if interval growth is noted...
  18. pmc MIB-1 labeling index predicts recurrence in intraventricular central neurocytomas
    Gurvinder Kaur
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA 94143, USA
    J Clin Neurosci 20:89-93. 2013
    ..Thus, in patients with CN who were treated with STR, histology demonstrating a MIB-1 labeling index >4% can be a clinically useful prognostic indicator and can help guide adjuvant treatment...
  19. doi Implications of cystic features in vestibular schwannomas of patients undergoing microsurgical resection
    Brian J Jian
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, California, USA
    Neurosurgery 68:874-80; discussion 879-80. 2011
    ..Cystic vestibular schwannomas (VSs) are described as being more aggressive than solid tumors...
  20. doi The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas
    Michael E Sughrue
    Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California 94143, USA
    J Neurosurg 113:1029-35. 2010
    ....
  21. doi Epidermal growth factor module-containing mucin-like receptor 2 is a newly identified adhesion G protein-coupled receptor associated with poor overall survival and an invasive phenotype in glioblastoma
    Martin J Rutkowski
    Brain Tumor Research Center, Department of Neurological Surgery, University of California, 505 Parnassus Ave, San Francisco, CA 94143, USA
    J Neurooncol 105:165-71. 2011
    ..The invasive phenotype conferred by EMR2 correlates with clinical data demonstrating poor survival in glioblastoma patients who express high levels of EMR2 in their tumor...
  22. doi Predictors of mortality following treatment of intracranial hemangiopericytoma
    Martin J Rutkowski
    Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California, USA
    J Neurosurg 113:333-9. 2010
    ..A systematic review of the published literature was performed to ascertain predictors of death following treatment for intracranial HPC...
  23. pmc Anatomic location is a risk factor for atypical and malignant meningiomas
    Ari J Kane
    Brain Tumor Research Center, Department of Neurological Surgery, University of California at San Francisco, San Francisco, California 94143, USA
    Cancer 117:1272-8. 2011
    ..Hence, the authors have reviewed a large series of their patients to determine risk factors for higher-grade pathology, with particular interest paid to tumor location...
  24. doi Incidence, risk factors, and outcome of venous infarction after meningioma surgery in 705 patients
    Michael E Sughrue
    Brain Tumor Research Center, Department of Neurological Surgery, University of California at San Francisco, 505 Parnassus Avenue, P O Box 0112, San Francisco, California 94143, USA
    J Clin Neurosci 18:628-32. 2011
    ..9%, χ(2)p<0.05). We demonstrated that the most important factor determining the risk of venous infarction is the approach used to access the tumor...
  25. doi Factors affecting outcome following treatment of patients with cavernous sinus meningiomas
    Michael E Sughrue
    Department of Neurological Surgery, University of California at San Francisco, California 94143, USA
    J Neurosurg 113:1087-92. 2010
    ..The authors performed a meta-analysis of reported tumor control and survival rates of patients described in the published literature, with an emphasis on specific prognostic factors...
  26. doi Postoperative seizures following the resection of convexity meningiomas: are prophylactic anticonvulsants indicated? Clinical article
    Michael E Sughrue
    Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California, USA
    J Neurosurg 114:705-9. 2011
    ..Given the paucity of tumor-type and site-specific data, the authors evaluated the incidence of postoperative seizures in patients with convexity meningiomas and no prior seizures...
  27. doi A prospective study of hearing preservation in untreated vestibular schwannomas
    Michael E Sughrue
    Department of Neurological Surgery, University of California, San Francisco, 94143, USA
    J Neurosurg 114:381-5. 2011
    ..In this paper the authors present an analysis of prospectively collected outcomes in patients with untreated VS from their institution that confirms their previous findings...
  28. doi The effect of the 2003 Consensus Reporting Standards on publications describing patients with vestibular schwannoma treated with stereotactic radiosurgery
    Seunggu J Han
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA 94117, USA
    J Clin Neurosci 19:1144-7. 2012
    ..001). Our findings suggest a potentially significant impact of the Guidelines on the quality of the information included in studies...
  29. doi The long-term postsurgical prognosis of patients with pineoblastoma
    Matthew Tate
    Department of Neurological Surgery, University of California, San Francisco, San Francisco, California 94143 0350, USA
    Cancer 118:173-9. 2012
    ..For this report, the authors comprehensively summarized the existing literature on patients with pineoblastoma and identified the variables and treatments that had an impact patient on outcomes...
  30. doi The value of intraoperative facial nerve electromyography in predicting facial nerve function after vestibular schwannoma surgery
    Michael E Sughrue
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA 94143, USA
    J Clin Neurosci 17:849-52. 2010
    ..In conclusion, while facial nerve EMG is a critical adjunct for locating the facial nerve intraoperatively, its predictive value for facial nerve function remains to be determined...
  31. doi Impact of bevacizumab chemotherapy on craniotomy wound healing
    Aaron J Clark
    Department of Neurological Surgery, University of California, San Francisco, California 94143 0112, USA
    J Neurosurg 114:1609-16. 2011
    ..Phase II trials reported 4%-6% impaired wound healing for bevacizumab initiated postoperatively. The effect of preoperative bevacizumab on subsequent craniotomy healing has not been addressed...
  32. doi A critical evaluation of vestibular schwannoma surgery for patients younger than 40 years of age
    Michael E Sughrue
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, California 94143, USA
    Neurosurgery 67:1646-53; discussion 1653-4. 2010
    ..There are few published prospective data sets specifically focusing on patients younger than 40 years old undergoing microsurgery for vestibular schwannoma...
  33. doi Intratumoral hemorrhage and fibrosis in vestibular schwannoma: a possible mechanism for hearing loss
    Michael E Sughrue
    Department of Neurological Surgery, University of California, San Francisco, 94143, USA
    J Neurosurg 114:386-93. 2011
    ..In this case-control study, the authors investigated the relationship between preoperative hearing loss and histological changes such as intratumoral microhemorrhage and extensive fibrosis...
  34. doi Reporting standard compliance in publications of vestibular schwannoma patients treated with microsurgery
    Seunggu J Han
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, California 94117, USA
    Otol Neurotol 33:648-50. 2012
    ..In 2003, Kanzaki and colleagues published a set of reporting standards for vestibular schwannoma (VS) to serve as a guide for future publication, with the specific purpose of promoting standardization of reporting results in VS...
  35. doi Atypia predicting prognosis for intracranial extraventricular neurocytomas
    Ari J Kane
    Department of Neurological Surgery, University of California at San Francisco, California 94143, USA
    J Neurosurg 116:349-54. 2012
    ..The authors present an analysis of all reported intracranial EVN cases to establish if tumor histopathological features can substratify EVN into groups with differing prognosis and help guide treatment decisions...
  36. pmc CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival
    Isaac Yang
    Department of Neurological Surgery, University of California at San Francisco, 505 Parnassus Avenue, San Francisco, California 94117, USA
    J Clin Neurosci 17:1381-5. 2010
    ..006). Thus, CD8+ T-cell infiltrate is associated with prolonged survival. Our data provide the impetus for more sophisticated studies to further elucidate prospectively the specific T-cell subtypes associated with long-term survival...
  37. doi Microscopic endonasal transsphenoidal pituitary adenomectomy in the pediatric population
    Phiroz E Tarapore
    Department of Neurological Surgery, University of California, San Francisco, California, USA
    J Neurosurg Pediatr 7:501-9. 2011
    ..The authors of this report describe their 10-year experience in managing pituitary adenomas via the microscopic endonasal transsphenoidal approach in a pediatric population...
  38. doi Prevalence of previous extracranial malignancies in a series of 1228 patients presenting with meningioma
    Michael E Sughrue
    Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California 94143, USA
    J Neurosurg 113:1115-21. 2010
    ..The authors present an analysis of the prevalence of previously diagnosed extracranial malignancies at the time of meningioma diagnosis in 1228 patients evaluated at a single institution...
  39. doi Posttreatment prognosis of patients with esthesioneuroblastoma
    Ari J Kane
    Department of Neurological Surgery, University of California, San Francisco, California 94143, USA
    J Neurosurg 113:340-51. 2010
    ..The objective was to ascertain what variables predict prognosis in these patients and to determine the relative effect of different therapies...
  40. pmc Association of morbidity with extent of resection and cavernous sinus invasion in sphenoid wing meningiomas
    Michael E Ivan
    Department of Neurological Surgery, University of California, San Francisco, California
    J Neurol Surg B Skull Base 73:76-83. 2012
    ..In conclusion, complete excision of SWMs is always recommended whenever possible, but surgeons should acknowledge that there is nonetheless a chance of recurrence and should weigh this against the risk of causing cranial nerve injuries...
  41. pmc Supratentorial hemangioblastoma: clinical features, prognosis, and predictive value of location for von Hippel-Lindau disease
    Steven A Mills
    Department of Neurological Surgery, University of California, San Francisco, CA, USA
    Neuro Oncol 14:1097-104. 2012
    ..Von Hippel-Lindau disease is positively correlated with supratentorial hemangioblastoma when compared with non-supratentorial CNS hemangioblastomas, particularly when present in the sellar/suprasellar region...
  42. pmc Factors influencing overall survival rates for patients with pineocytoma
    Aaron J Clark
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA 94117, USA
    J Neurooncol 100:255-60. 2010
    ..Gross total resection is the most appropriate treatment for pineocytoma. The potential benefit of conventional radiotherapy for the treatment of these lesions is unproven, and little evidence supports its use at present...
  43. doi Treatment decision making based on the published natural history and growth rate of small meningiomas
    Michael E Sughrue
    Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California 94143, USA
    J Neurosurg 113:1036-42. 2010
    ..To address this need, the authors systematically reviewed the published literature regarding the natural history of small, untreated meningiomas...
  44. pmc Immunological considerations of modern animal models of malignant primary brain tumors
    Michael E Sughrue
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, California, USA
    J Transl Med 7:84. 2009
    ..As this review demonstrates, many of these models have inherent immune system limitations, and the impact of these limitations on studies on the influence of pre-clinical therapeutics testing warrants further attention...
  45. doi Hearing preservation rates after microsurgical resection of vestibular schwannoma
    Michael E Sughrue
    Department of Neurological Surgery, University of California at San Francisco, 505 Parnassus Ave, San Francisco, CA 94143, USA
    J Clin Neurosci 17:1126-9. 2010
    ..Use of the MCF demonstrates superior hearing outcomes to the RS approach, even after correcting for the effect of the increased size of tumors addressed by the RS approach...
  46. doi Current management of middle cerebral artery aneurysms: surgical results with a "clip first" policy
    Ana Rodríguez-Hernández
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, California 94143, USA
    Neurosurgery 72:415-27. 2013
    ..Surgical results with middle cerebral artery (MCA) aneurysms have been excellent, raising debate about the respective roles of surgical and endovascular therapy...
  47. doi Clinical characteristics and surgical outcomes of patients presenting with meningiomas arising predominantly from the floor of the middle fossa
    Michael E Sughrue
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, California 94117, USA
    Neurosurgery 67:80-6; discussion 86. 2010
    ..Little is known regarding meningiomas that primarily arise from the floor of the middle fossa as opposed to the sphenoid wing, the cavernous sinus, the anterior petrous ridge, or the lateral convexity dura...
  48. doi The relative patient benefit of gross total resection in adult choroid plexus papillomas
    Michael Safaee
    Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94143 0112, USA
    J Clin Neurosci 20:808-12. 2013
    ..Our analysis suggests that these lesions are not as indolent as previously thought and while GTR is preferred, it is not always curative...
  49. doi Contemporary management of pineocytoma
    Aaron J Clark
    Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Avenue, M779, Box 0112, San Francisco, CA 94117, USA
    Neurosurg Clin N Am 22:403-7, ix. 2011
    ..Although aggressive surgery in the pineal region carries the risk of neurologic injury, gross total resection should be attempted for pineocytoma...
  50. pmc Long term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas
    Edward F Chang
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA, USA
    Pituitary 13:223-9. 2010
    ..Our data suggest that when performed by experienced transsphenoidal surgeons, durable tumor control can be obtained in these frequently locally aggressive tumors with acceptable rates of post-operative morbidity...
  51. doi Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology
    Isaac Yang
    Department of Neurosurgery, University of California, Los Angeles, California, USA
    J Neurosurg 115:505-11. 2011
    ..In this paper the authors demonstrate that characterization of the intratumoral inflammatory infiltrate can distinguish high-grade glioblastoma from low-grade pilocytic astrocytoma...
  52. pmc EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target
    Ari J Kane
    Department of Neurological Surgery, Division of Neuropathology, University of California at San Francisco, San Francisco, California 94143, USA
    Neuroreport 21:1018-22. 2010
    ..EMR-3 is a potential mediator of cellular invasion in GBM. Given the poor survival associated with high levels of EMR-3 expression in glioma patients, our results provide impetus to explore EMR-3 as a potential therapeutic target...
  53. doi Clinical features and post-surgical outcome of patients with astroblastoma
    Michael E Sughrue
    Department of Neurological Surgery, University of California, San Francisco, California 94117, USA
    J Clin Neurosci 18:750-4. 2011
    ..463). Thus, we have reported the results of a summary of the literature on astroblastomas and have accurately described outcome characteristics using a data set that would be difficult to accumulate at a single center treating this tumor...
  54. pmc Implications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma
    James S Waldron
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, California 94123, USA
    J Clin Neurosci 17:1543-7. 2010
    ..In addition, our results raise the possibility of combining T-cell based immunotherapy protocols with clinical inhibitors of the PI3K/Akt/mTOR pathway...
  55. pmc The prognostic implications of Hyam's subtype for patients with Kadish stage C esthesioneuroblastoma
    Gurvinder Kaur
    Department of Neurological Surgery, University of California at San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA
    J Clin Neurosci 20:281-6. 2013
    ..The patient's tumor histology (Hyam's criteria) appeared to be the best way of predicting the prognosis and for selecting patients for adjuvant radiotherapy...
  56. doi Minimally invasive approaches to the pineal region
    Michael E Sughrue
    Comprehensive Brain Tumor Center, Department of Neurological Surgery, University of Oklahoma, 1000 North Lincoln Boulevard, Suite 400, Oklahoma City, OK 73104 5023, USA
    Neurosurg Clin N Am 22:381-4, viii. 2011
    ..Although this review, for the sake of brevity, focuses on the infratentorial-supracerebellar approach, many of these principles can be adapted to other approaches, such as the occipital transtentorial, without excessive imagination...
  57. doi A meta-analysis of predictors of seizure freedom in the surgical management of focal cortical dysplasia
    Nathan C Rowland
    UCSF Comprehensive Epilepsy Center, Department of Neurological Surgery, University of California, San Francisco, California 94143 0112, USA
    J Neurosurg 116:1035-41. 2012
    ..The authors' aim was to determine the prognostic factors for seizure control in FCD by performing a meta-analysis of the published literature...
  58. doi The molecular pathology of central neurocytomas
    Ari J Kane
    Department of Neurological Surgery, University of California at San Francisco, 505 Parnassus Avenue, San Francisco, California 94143, USA
    J Clin Neurosci 18:1-6. 2011
    ..Our discussion is expanded to include important and related insights into the cellular origin and classification of central nervous system tumors...
  59. pmc The complement cascade as a mediator of tissue growth and regeneration
    Martin J Rutkowski
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA 94143, USA
    Inflamm Res 59:897-905. 2010
    ..Here, we describe the complement cascade as a mediator of tissue growth and regeneration...
  60. doi Preservation of facial nerve function after resection of vestibular schwannoma
    Michael E Sughrue
    Department of Neurological Surgery, University of California at San Francisco, 505 Parnassus Ave, San Francisco, CA 94143, USA
    Br J Neurosurg 24:666-71. 2010
    ..The objective of this study was to provide a comprehensive assessment of reported outcomes for facial nerve preservation after VS surgery...
  61. doi The rise and fall of "biopsy and radiate": a history of surgical nihilism in glioma treatment
    Seunggu J Han
    Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Avenue, M779, San Francisco, CA 94117, USA
    Neurosurg Clin N Am 23:207-14, vii. 2012
    ....
  62. pmc Giant intracranial aneurysms: evolution of management in a contemporary surgical series
    Michael E Sughrue
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, California 94143, USA
    Neurosurgery 69:1261-70; discussion 1270-1. 2011
    ..Many significant microsurgical series of patients with giant aneurysms predate changes in practice during the endovascular era...
  63. doi Craniopharyngioma: a comparison of tumor control with various treatment strategies
    Isaac Yang
    Department of Neurological Surgery, University of California, San Francisco, California, USA
    Neurosurg Focus 28:E5. 2010
    ..Here, the authors summarize the published literature regarding rates of tumor control with various treatment modalities for craniopharyngiomas...
  64. pmc Human glioma demonstrates cell line specific results with ATP-based chemiluminescent cellular proliferation assays
    Michael E Sughrue
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, California 94143, USA
    J Clin Neurosci 17:1573-7. 2010
    ..Our findings suggest that different glioma cell lines have unique levels of ATP per cell...
  65. doi Utility of the immediate postoperative cortisol concentrations in patients with Cushing's disease
    Michael E Sughrue
    California Center for Pituitary Disorders, University of California, San Francisco, California 94143 0350, USA
    Neurosurgery 67:688-95; discussion 695. 2010
    ..Several investigators have recommended serial measurements of serum cortisol in the days following pituitary surgery to identify patients at risk of recurrence...
  66. doi Complement and the central nervous system: emerging roles in development, protection and regeneration
    Martin J Rutkowski
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, CA 94143, USA
    Immunol Cell Biol 88:781-6. 2010
    ....
  67. doi Signaling pathways in cranial chondrosarcoma: potential molecular targets for directed chemotherapy
    Orin Bloch
    Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, California 94143, USA
    J Clin Neurosci 18:881-5. 2011
    ..The data suggest that targeting these pathways may improve control of cranial chondrosarcoma and decrease the need for hazardous recurrent operations...
  68. doi Embolization of skull base meningiomas and feeding vessels arising from the internal carotid circulation
    James S Waldron
    Department of Neurological Surgery, University of California, San Francisco, San Francisco, California 94123, USA
    Neurosurgery 68:162-9; discussion 169. 2011
    ..Practice patterns regarding the preoperative embolization of skull base tumors vary widely among institutions and are driven by surgeon preference and concerns about safety...
  69. doi Cancer and the complement cascade
    Martin J Rutkowski
    Department of Neurological Surgery, University of California at San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA
    Mol Cancer Res 8:1453-65. 2010
    ..Given that the traditionally held functions for the complement system include innate immunity and cancer defense, our review suggests a new way of thinking about the role of complement proteins in neoplasia...
  70. doi Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics
    Michael E Sughrue
    Department of Otolaryngology Head and Neck Surgery, University of California at San Francisco, 94143 0350, USA
    J Neurosurg 114:359-66. 2011
    ..A better understanding of the molecular pathobiology of VSs may lead to novel therapeutics to augment current modalities of treatment while minimizing morbidity...
  71. doi A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma
    Isaac Yang
    Department of Neurological Surgery, University of California at San Francisco, California 94117, USA
    J Neurosurg 112:851-9. 2010
    ..Their aim was to objectively characterize the prognostic factors that contribute to hearing preservation after GKS, as well as methodically summarize the reported literature describing hearing preservation after GKS for VS...
  72. doi Extreme correction of hyponatremia in a patient treated with intravenous conivaptan
    Michael E Sughrue
    California Center for Pituitary Disorders at University of California, San Francisco, 400 Parnassus Avenue, Room A 808, San Francisco, California 94143 0350, USA
    J Clin Neurosci 17:1331-4. 2010
    ..Thus, the exact clinical situation should be taken into consideration, especially in cases of subacute to chronic hyponatremia, where such an extreme correction could lead to neurologic devastation...
  73. doi The next step: innovative molecular targeted therapies for treatment of intracranial chordoma patients
    Jeffrey J Barry
    Department of Neurological Surgery, University of California at San Francisco, San Francisco, California 94117, USA
    Neurosurgery 68:231-40; discussion 240-1. 2011
    ..Patients who relapse or cannot undergo a complete en bloc resection generally have a poor prognosis. New agents for postoperative adjuvant treatment of chordomas are needed...
  74. doi Marked reduction in wound complication rates following decompressive hemicraniectomy with an improved operative closure technique
    Michael E Sughrue
    Department of Neurological Surgery, Brain and Spinal Injury Center, University of California at San Francisco, 1001 Potrero Avenue, Building 1, Room 101, Box 0899, San Francisco, CA 94143, USA
    J Clin Neurosci 18:1201-5. 2011
    ..05), compared to other, more standard, techniques. Thus, attention to closure of hemicraniectomy wounds can markedly reduce the rate of wound complications, thus improving the risk-to-benefit ratio of this procedure...
  75. doi Risk profile associated with convexity meningioma resection in the modern neurosurgical era
    Nader Sanai
    Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California 94143, USA
    J Neurosurg 112:913-9. 2010
    ..Although meningiomas are commonly found along the supratentorial convexity, the risk profile associated with this subset of lesions in the modern neurosurgical era is unknown...